Luteinizing-hormone-releasing hormone agonist treatment in patients with previously failed folliculogenesis during in vitro fertilization therapy.
MacLachlan
V
V
Department of Obstetrics and Gynaecology, Monash University, Melbourne, Australia.
Besanko
M
M
Wade
H
H
Morrow
L
L
O'Shea
F
F
Trounson
A
A
Healy
D
D
D002064:Buserelin / Q000627:therapeutic use*; D004958:Estradiol / Q000097:blood; D005260:Female; D005307:Fertilization in Vitro; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008597:Menstrual Cycle; D017274:Nafarelin; D006080:Ovarian Follicle / Q000187:drug effects / Q000502:physiology*; D010060:Ovulation / Q000187:drug effects
D017274:Nafarelin; D007987:Gonadotropin-Releasing Hormone; D004958:Estradiol; D002064:Buserelin